Cargando…
What’s new in dry eye disease diagnosis? Current advances and challenges
Dry eye disease (DED) is a commonly encountered condition in general ophthalmology practice and imparts a significant socioeconomic burden. Despite its prevalence, there remain challenges regarding its diagnosis and management. A major reason behind these challenges is the fact that DED represents a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305205/ https://www.ncbi.nlm.nih.gov/pubmed/30613376 http://dx.doi.org/10.12688/f1000research.16468.1 |
_version_ | 1783382513951965184 |
---|---|
author | Aggarwal, Shruti Galor, Anat |
author_facet | Aggarwal, Shruti Galor, Anat |
author_sort | Aggarwal, Shruti |
collection | PubMed |
description | Dry eye disease (DED) is a commonly encountered condition in general ophthalmology practice and imparts a significant socioeconomic burden. Despite its prevalence, there remain challenges regarding its diagnosis and management. A major reason behind these challenges is the fact that DED represents an umbrella term that encompasses many different underlying conditions and pathophysiological mechanisms. The purpose of this article is to highlight aspects of DED pathophysiology and focus on targeted diagnostic and therapeutic approaches to this multifactorial, chronic condition. |
format | Online Article Text |
id | pubmed-6305205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-63052052019-01-03 What’s new in dry eye disease diagnosis? Current advances and challenges Aggarwal, Shruti Galor, Anat F1000Res Review Dry eye disease (DED) is a commonly encountered condition in general ophthalmology practice and imparts a significant socioeconomic burden. Despite its prevalence, there remain challenges regarding its diagnosis and management. A major reason behind these challenges is the fact that DED represents an umbrella term that encompasses many different underlying conditions and pathophysiological mechanisms. The purpose of this article is to highlight aspects of DED pathophysiology and focus on targeted diagnostic and therapeutic approaches to this multifactorial, chronic condition. F1000 Research Limited 2018-12-19 /pmc/articles/PMC6305205/ /pubmed/30613376 http://dx.doi.org/10.12688/f1000research.16468.1 Text en Copyright: © 2018 Aggarwal S and Galor A http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Aggarwal, Shruti Galor, Anat What’s new in dry eye disease diagnosis? Current advances and challenges |
title | What’s new in dry eye disease diagnosis? Current advances and challenges |
title_full | What’s new in dry eye disease diagnosis? Current advances and challenges |
title_fullStr | What’s new in dry eye disease diagnosis? Current advances and challenges |
title_full_unstemmed | What’s new in dry eye disease diagnosis? Current advances and challenges |
title_short | What’s new in dry eye disease diagnosis? Current advances and challenges |
title_sort | what’s new in dry eye disease diagnosis? current advances and challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305205/ https://www.ncbi.nlm.nih.gov/pubmed/30613376 http://dx.doi.org/10.12688/f1000research.16468.1 |
work_keys_str_mv | AT aggarwalshruti whatsnewindryeyediseasediagnosiscurrentadvancesandchallenges AT galoranat whatsnewindryeyediseasediagnosiscurrentadvancesandchallenges |